<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="188800">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00635739</url>
  </required_header>
  <id_info>
    <org_study_id>1493</org_study_id>
    <nct_id>NCT00635739</nct_id>
  </id_info>
  <brief_title>Effect of Whey Protein Supplementation and Resistance Exercise on Muscle Parameters in Older Adults</brief_title>
  <official_title>Efficacy of Whey Protein Supplementation on Resistance Exercise-Induced Changes in Muscle Strength, Fat Free Mass, and Function in Mobility-Limited Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Dairy Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is looking at the effects of a whey protein nutritional supplement on
      changes in muscle mass, strength and physical function in response to a 6 month program of
      strength training exercise.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>Baseline, mid-study and end of study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline and end of study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Mobility Limitation</condition>
  <arm_group>
    <arm_group_label>A, 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>A, 2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein</intervention_name>
    <description>powdered, 46g supplement dissolved in fluids, twice daily</description>
    <arm_group_label>A, 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Maltodextrin placebo</intervention_name>
    <description>powdered, 46g supplement dissolved in fluids, twice daily</description>
    <arm_group_label>A, 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Females 70-85 yrs

          -  Community dwelling

          -  Short Physical Performance Battery score &lt; 10

          -  BMI = 21-32.5

        Exclusion Criteria:

          -  Acute or terminal illness

          -  Mini Mental State Exam &lt; 23

          -  Myocardial infarction in previous 6 months, symptomatic coronary artery disease, or
             congestive heart failure

          -  Upper or lower extremity fracture in previous 6 months

          -  Uncontrolled hypertension (&gt;150/90 mm Hg).

          -  Neuromuscular diseases and drugs which affect neuromuscular function.

          -  Hormone replacement therapy

          -  eGFR &lt;30 mL/min/1.73m2

          -  Types I and II Diabetes Mellitus

          -  Dietary protein intake &lt; 0.8 g.kg-1.day-1

          -  Disorders of nutrient absorption

          -  Milk, or whey allergy

          -  Sulfa drugs and allergy to PABA-containing sunscreens
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roger A Fielding, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jean Mayer USDA Human Nutrition Research Center on Aging</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jean Mayer USDA Human Nutrition Research Center on Aging</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <lastchanged_date>May 30, 2012</lastchanged_date>
  <firstreceived_date>March 7, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tufts University</investigator_affiliation>
    <investigator_full_name>Roger A Fielding</investigator_full_name>
    <investigator_title>Director and Senior Scientist, Professor of Nutrition, Jean Mayer USDA Human Nutrition Research Center on Aging.</investigator_title>
  </responsible_party>
  <keyword>Whey protein</keyword>
  <keyword>Resistance exercise</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Mobility disability</keyword>
  <keyword>Physical function</keyword>
  <keyword>Muscle mass</keyword>
  <keyword>Muscle strength</keyword>
  <keyword>Older Adults</keyword>
  <keyword>Mobility-Limited</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Mobility Limitation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
